Stereotactic body radiation therapy for bone oligometastases.
Fiche publication
Date publication
octobre 2023
Journal
Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique
Auteurs
Membres identifiés du Cancéropôle Est :
Dr FAIVRE Jean-Christophe
Tous les auteurs :
Naessens C, Chamois J, Supiot S, Faivre JC, Arnaud A, Thureau S
Lien Pubmed
Résumé
Stereotactic body radiation therapy is effective for the local management of oligometastases (at most five metastases) with a benefit in survival and local control. Most studies on the management of oligometastases focus on all oligometastatic sites in primary cancer and very few focus on a single oligometastatic site. In particular, there are few data on bone oligometastases, which represent one of the preferred sites for secondary cancer locations. This article focuses on the benefit of stereotactic radiotherapy for bone oligometastases of all cancers by histological types, and reviews the results of major studies in this field.
Mots clés
Bone metastases, Métastases osseuses, Oligometastases, Oligométastases, Radiotherapy, Radiothérapie, Radiothérapie stéréotaxique, Stereotactic radiotherapy
Référence
Cancer Radiother. 2023 10 12;: